AzTrials
AzTrials

StressAdapptNCT06248762

PPI and Mindfulness App for Parents of Children with a NDD

A study testing Adappt in people with Stress and Mental Health, run by University of Twente at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

An app based on positive psychology and mindfulness to support the mental well-being of parents of children with a Neurodevelopmental Disorder (NDD) was developed and will be evaluated on effectiveness. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stress, Mental Health, Mental Well-being
What is being tested?
Adappt
Could I receive a placebo?
No, everyone receives an active treatment
How many people
212 participants
Where
1 siteNetherlands
Study dates
3 Dec 2024to Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • at least 18 years
  • parent of one or more children (< 18 years) diagnosed with or suspected of a NDD
  • having access to internet
  • in possession of an e-mail address,
  • in possession of a smartphone or tablet
  • willing to use the digital intervention for a month, daily for approximately 15 minutes a day.

Who cannot join

  • presence of severe anxiety symptoms
  • presence of moderately severe to severe depressive symptoms
  • being in treatment for mental health issues (the parent self)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ernst Bohlmeijer, Prof. Dr. contact

e.t.bohlmeijer@utwente.nl

Netherlands1 site, 1 recruiting
  • University of Twente

    Enschede

    Recruiting

Other trials in Netherlands

About this study

Official title: Effectiveness of a Positive Psychology and Mindfulness Based App for Parents of Children with a Neurodevelopmental Disorder (NDD): Study Protocol of a Pragmatic Randomized Controlled Trial

An app based on positive psychology and mindfulness to support the mental well-being of parents of children with a Neurodevelopmental Disorder (NDD) was developed and will be evaluated on effectiveness.

Read the detailed description

This pragmatic randomized controlled trial aims to assess the effectiveness of the Adappt app, an app developed to support the mental well-being of parents of children with a neurodevelopmental disorder (NDD), such as autism and ADHD. This app was developed since research has shown that these parents experience higher stress levels than parents of typically developing children. Furthermore, the app was developed in collaboration with parents of children with a NDD, mental health care professionals and scientists in Europe.

Being tested
Adappt
Keywords
ability to adapt, Adappt
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AdapptOther

    An app to support parents of children with a NDD

Study groups in NCT06248762
Study groupRoleWhat they receive
Intervention conditionExperimentalParticipants will use the app for 4 weeks, daily for 10-15 minutes
Receives: Other: Adappt
Waitlist control conditionOtherParticipants in the control condition will start using the app 4 months after the start (baseline)
Receives: Other: Adappt

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ability to Adapt

    Measured with the10-item Generic Sense of Ability to Adapt Scale (GSAAS). An average score will be calculated ranging from 0 to 4, with higher scores being indicative of higher perceived ability to adapt.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

Secondary outcomes (11)
  1. Mental well-being

    Measured with the 14-item Mental Health Continuum - Short Form (MHC-SF). Averages will be calculated for mental well-being and the subscales emotional, social and psychological well-being, ranging from 0 to 5, with higher scores being indicative for more mental (social, emotional and psychological) well-being.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  2. Stress

    Measured with the-10 item perceived stress scale (PSS). Sum scores will be calculated ranging from 0 to 40, with higher scores being indicative of larger levels of perceived stress.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  3. Anxiety

    Measured with the 7-item Hospital Anxiety and Depression Scale (HADS-A). A sum score will be calculated ranging from 0 to 21, with higher scores being indicative of larger anxiety levels.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  4. Depressive symptoms

    Measured with the 9-item Patient Health Questionnaire (PHQ-9). Sum scores will be calculated ranging from 0 to 27, with higher scores being indicative for larger depressive levels.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  5. Parenting self-efficay and behavior of child

    Measured with the 24-item Child Adjustment and Parent Efficacy Scale - Developmental Disability (CAPES-DD). A sum score will be calculated for parental self-efficacy, ranging from 16 to 160, with higher scores being indicative of larger parental self-efficacy levels. A sum score will be calculated for the child behavioral subscales: emotional problems (0-4), behavioral problems (0-30), prosocial behavior (0-24) and total problems (0-48).

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  6. Savoring the moment

    Measured with the 8-item savoring the moment subscale of the Savoring Beliefs Inventory (SBI). Sum scores ranging from -24 to +24 will be calculated, with higher scores being indicative of a stronger savoring in the moment.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  7. Self-reassuring

    Measured with 5-item reassuring-self subscale of the Forms of Criticism/Self-Attacking and Self- Reassuring Scale Short Form (FSCRS-SF). Sum scores ranging from 0 to 20 will be calculated, with higher scores being indicative for a larger sense of self-reassurance.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  8. Postive aspects of caregiving

    Measured with the 9-item Positive Aspects of Caregiving (PAC). A sum score will be calculated ranging from 9 to 45, with higher scores being indicative of more positive aspects of caregiving.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  9. Psychological flexibility

    Measured with the 7-item Acceptance and Action Questionnaire-II (AAQ-II). Sum scores will be calculated, ranging from 7 to 49, with higher scores being indicative for larger levels of psychological flexibility.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  10. Positive coping skills

    Measured with the (16 items of the) subscales Acceptance, Positive refocusing, Positive reappraisal, Putting into perspective of the Cognitive Emotion Regulation Questionnaire (CERQ). Sum scores ranging from 4 to 20 will be calculated for each subscale, with higher scores being indicative of larger cognitive strategy use frequency.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

  11. Mindfulness

    Measured with the 15-item Mindfulness Attention Awareness Scale (MAAS). Mean scores will be calculated ranging from 1 to 6, with higher scores being indicative of more mindfulness.

    Measured: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2024
  2. Study start3 Dec 2024
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Delayed waitlist control
Masking
None (open label)
Enrolment
212 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06248762
Sponsor's protocol ID
University of Twente
Acronym
Adappt
Status last verified
Feb 2025
First submitted
25 Jan 2024
Last updated
21 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual Participant Data (IPD) will not be shared

Publications

  • Tonis KJM, Drossaert CHC, Ten Klooster PM, Schaer M, Bourgeron T, Buitelaar JK, Sadaka Y, Freitag CM, Lapidus KM, Chiocchetti AG, Staal WG, Bohlmeijer ET. Effectiveness of a positive psychology and mindfulness-based app on mental health for parents of children with a neurodevelopmental disorder: study protocol of a pragmatic international randomized controlled trial. Trials. 2024 Jun 26;25(1):412. doi: 10.1186/s13063-024-08256-w.

    PubMed 38926739

Questions about this trial

What is this clinical trial studying?

A study testing Adappt in people with Stress and Mental Health, run by University of Twente at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kim Tönis, MSc (+31 53 489 1545, k.j.m.tonis@utwente.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ability to Adapt (time frame: Change from baseline to post intervention (1 month post baseline) and first follow up (4 months post baseline)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06248762, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in